The Illinois Medical Cannabis Advisory Board recommended adding several disorders to the list of conditions that qualify for treatment under the state’s medical marijuana law.
The board was petitioned to consider adding anorexia nervosa, anxiety, chronic post-operative pain, diabetes, Ehlers-Danlos Syndrome, essential thrombcythemia with a JAK 2 mutation, irritable bowel syndrome, migraine, Neuro-Behcet’s autoimmune disease, neuropathy (peripheral and diabetic), osteoarthritis, polycystic kidney disease, PTSD, and superior canal dehiscence syndrome to the list of debilitating conditions that might be treated with marijuana under the Illinois Medical Cannabis program.
The board met in Chicago on Monday, May 4, 2015, to review – and hear testimony on – possible additions to the list of conditions which may be treated with medical cannabis. They voted in favor of approving conditions including anorexia nervosa, osteoarthritis, diabetic neuropathy, periphery polyneuropathy, migraines, irritable bowel syndrome, and post-traumatic stress disorder to the list.
Diabetes, anxiety, and essential thrombcythemia were rejected by the board.
The list is only recommendations from the advisory board, which must ultimately be passed on to the Illinois Department of Public Health for a final decision on which conditions might be added to the list of those approved for treatment with medical marijuana.
